Abstract
We describe a parametric time-to-event model for idiopathic pulmonary fibrosis (IPF) exacerbations and identify predictors of exacerbation risk using data obtained for the tyrosine-kinase inhibitor nintedanib in two phase III studies (INPULSIS-1/2). Parametric survival analysis was performed on time to first exacerbation (censoring on day 372), with univariate analysis to select statistically significant covariates (P = 0.05). Multivariate covariate models were developed using stepwise covariate modeling with forward inclusion (P = 0.05) and backward elimination (P = 0.01). Sixty-three first exacerbation events were reported across 1,061 subjects in the INPULSIS studies. Baseline and decline of forced vital capacity (FVC)/percent-predicted FVC (%pFVC), supplemental oxygen use, baseline CO diffusing capacity and age were statistically significant in the univariate analysis. The final covariate model included decline in FVC to week 52, baseline %pFVC, supplemental oxygen use, and age. The developed model may be used to identify patients at high risk of IPF exacerbations and accelerate development of novel treatments.
Cite
CITATION STYLE
Tang, F., Weber, B., Stowasser, S., & Korell, J. (2020). Parametric Time-to-Event Model for Acute Exacerbations in Idiopathic Pulmonary Fibrosis. CPT: Pharmacometrics and Systems Pharmacology, 9(2), 87–95. https://doi.org/10.1002/psp4.12485
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.